Cite
HARVARD Citation
Johnson, T. et al. (n.d.). 789. Evaluation of Bezlotoxumab for Prevention of Recurrent Clostridioides difficile Infection in Patients at High Risk for Recurrence. Open forum infectious diseases. pp. S438-S439. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Johnson, T. et al. (n.d.). 789. Evaluation of Bezlotoxumab for Prevention of Recurrent Clostridioides difficile Infection in Patients at High Risk for Recurrence. Open forum infectious diseases. pp. S438-S439. [Online].